Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection.
Foster RG, Golden-Mason L, Rutebemberwa A, Rosen HR.
Dig Dis Sci. 2012 Feb;57(2):381-9. Epub 2011 Dec 20.
Related citations
Very low viral load (VLVL) relapse following treatment of naïve patients with chronic hepatitis C.
Hoefs JC, Aulakh VS, Ilagan BJ.
Dig Dis Sci. 2012 Jan;57(1):243-9. Epub 2011 Dec 4.
An integrated alcohol abuse and medical treatment model for patients with hepatitis C.
Proeschold-Bell RJ, Patkar AA, Naggie S, Coward L, Mannelli P, Yao J, Bixby P, Muir AJ.
Dig Dis Sci. 2012 Apr;57(4):1083-91. Epub 2011 Dec 2.
Ultra-rapid virological response, young age, low γ-GT/ALT-ratio, and absence of steatosis identify a subgroup of HCV Genotype 3 patients who achieve SVR with IFN-α(2a) monotherapy.
Amanzada A, Goralczyk A, Moriconi F, Blaschke M, Schaefer IM, van Thiel D, Mihm S, Ramadori G.
Dig Dis Sci. 2011 Nov;56(11):3296-304. Epub 2011 Oct 13.
Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma.
Miyatake H, Kobayashi Y, Iwasaki Y, Nakamura S, Ohnishi H, Kuwaki K, Toshimori J, Hagihara H, Nouso K, Yamamoto K.
Dig Dis Sci. 2012 Apr;57(4):1092-101. Epub 2011 Oct 12.
Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin.
Moore CM, George M, Van Thiel DH.
Dig Dis Sci. 2011 Oct;56(10):3032-7. Epub 2011 Aug 31.
Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C.
Ghosh S, Duseja A, Dhiman RK, Chawla YK.
Dig Dis Sci. 2012 Mar;57(3):820-1. Epub 2011 Sep 24.
Histological versus clinical cirrhosis in chronic hepatitis C: does race/ethnicity really matter?
Kohla M, Iwata S, Ea R, Keyhan S, Taylor R, Yu MC, Groshen S, Bonacini M.
Dig Dis Sci. 2012 Mar;57(3):771-6. Epub 2011 Sep 24.
Impact of calcineurin inhibitors on hepatitis C recurrence after liver transplantation.
Kim RD, Mizuno S, Sorensen JB, Schwartz JJ, Fujita S.
Dig Dis Sci. 2012 Feb;57(2):568-72. Epub 2011 Sep 1.
Clinical significance of discordant positive hepatitis C virus transcription-mediated amplification following end of treatment response.
Thadani A, Harley J, Rubin J, Lebovics E.
Dig Dis Sci. 2012 Jan;57(1):239-42. Epub 2011 Jul 14.
Direct medical care costs among pegylated interferon plus ribavirin-treated and untreated chronic hepatitis C patients.
Solomon M, Bonafede M, Pan K, Wilson K, Beam C, Chakravarti P, Spiegel B.
Dig Dis Sci. 2011 Oct;56(10):3024-31. Epub 2011 Jun 30.
Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.
Tohra SK, Taneja S, Ghosh S, Sharma BK, Duseja A, Dhiman RK, Das A, Chawla YK.
Dig Dis Sci. 2011 Aug;56(8):2449-55. Epub 2011 Jun 25.
Peginterferon alfa-2a is superior to peginterferon alfa-2b in the treatment of naïve patients with hepatitis C virus infection: meta-analysis of randomized controlled trials.
Singal AK, Jampana SC, Anand BS.
Dig Dis Sci. 2011 Aug;56(8):2221-6. Epub 2011 Jun 4. Review.
Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study.
Yee HS, Currie SL, Tortorice K, Cozen M, Shen H, Chapman S, Cunningham F, Monto A.
Dig Dis Sci. 2011 Aug;56(8):2439-48. Epub 2011 Jun 2.
Response to peginterferon-alfa 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 2.
Kanda T, Imazeki F, Azemoto R, Yonemitsu Y, Mikami S, Kita K, Takashi M, Sunaga M, Wu S, Nakamoto S, Tawada A, Arai M, Kato K, Yoshida Y, Koma Y, Fujiwara K, Fukai K, Suzuki N, Yokosuka O.
Dig Dis Sci. 2011 Nov;56(11):3335-42. Epub 2011 May 22.
Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics.
Yang L, Rudser KD, Higgins L, Rosen HR, Zaman A, Corless CL, David L, Gourley GR.
Dig Dis Sci. 2011 Nov;56(11):3305-15. Epub 2011 May 17.
The protease inhibitor era: an opportunity to improve the quality of care.
Muir AJ.
Dig Dis Sci. 2011 May;56(5):1252-4. No abstract available.
Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.
Shah AG, Smith PG, Sterling RK.
Dig Dis Sci. 2011 Oct;56(10):3038-44. Epub 2011 Apr 28.
Acoustic liver biopsy in patients with hepatitis C and advanced liver fibrosis using endoscopic ultrasound.
Vegesna A, Nazir A, Chung CY, Kane S, Thomas R, Miller L.
Dig Dis Sci. 2011 Oct;56(10):3053-7. Epub 2011 Apr 1.
Eradication of hepatitis C virus reduces the risk of hepatocellular carcinoma in patients with compensated cirrhosis.
Velosa J, Serejo F, Marinho R, Nunes J, Glória H.
Dig Dis Sci. 2011 Jun;56(6):1853-61. Epub 2011 Mar 5.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on